Immunobiological activities of a new nontoxic lipopolysaccharide from Acidiphilium GS18h/ATCC55963, a soil isolate from an Indian copper mine

FEMS Immunology and Medical Microbiology

Volumn 48, Issue 1, 2006, Pages 107-115

  Bera, Rabindranath ^a   Nayak, Abhijit ^a,b   Sarkar, Chinmoy ^a   Singh, Suman Kumar ^a   Ratha, Jagnyeswar ^a   Bhadra, Ranjan ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Division of Health and Education for Disabled   (India)

Author keywords

Acidiphilium strain GS18h ATCC55963; Cytokine; Lipopolysaccharide; Macrophage

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; COPPER; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID A; PYROGEN; TUMOR NECROSIS FACTOR ALPHA;

ACIDIPHILIUM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; DRUG PURIFICATION; FEMALE; HUMAN; HUMAN CELL; IMMUNOBIOLOGY; IMMUNOMODULATION; LIPID COMPOSITION; MACROPHAGE; MINING; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHODOBACTER CAPSULATUS; RHODOBACTER SPHAEROIDES; SEPTIC SHOCK; STRUCTURE ACTIVITY RELATION;

ACIDIPHILIUM; ANIMALS; COPPER; ESCHERICHIA COLI; IMMUNE TOLERANCE; INTERLEUKINS; LIPID A; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MINING; SHOCK, SEPTIC; SOIL MICROBIOLOGY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33748606670     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00131.x     Document Type: Article

References (35)

1. Amura CR, Silvertein R & Morrison DC (1998) Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect Immun 66: 5372-5378.
2. Banerjee PC, Ray MK, Koch C, Bhattacharyya S, Shivaji S & Stackebrandt E (1996) Molecular characterization of two acidophilic heterotrophic bacteria isolated from a copper mine of India. Syst Appl Microbiol 19: 78-82.
3. Basu S, Das S & Banerjee PC (1994) Lipoplysaccharides of the acidophilic heterotrophic bacteria Acidiphilium cryptum and Acidiphilium symbioticum. FEMS Microbiol Lett 118: 65-70.
4. Bera R, Nayak A, Sen AK, Chowdhury BP & Bhadra R (2005) Isolation and characterisation of the lipopolysaccharide from Acidiphilium strain GS 18h/ATCC55963, a soil isolate of Indian copper mine. FEMS Microbiol Lett 246: 183-190.
5. Calandra T, Gerain J, Heumann D, Baumgartner JD & Glauser MP (1991) High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines; the Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 91: 23-29.
6. Cannon JG (1992) Endotoxin and cytokine responses in human volunteers. Bacterial Endotoxic Lipopolysaccharides (Ryan JL & Morrison DC, eds), pp. 312-326. CRC Press Inc., Boca Raton, FL.
7. Cerami A & Beutler B (1988) The role of cachectin/TNF in endotoxic shock and cachexia. Immunol Today 9: 28-31.
8. Dinarello CA (1988) Biology of interleukin 1. FASEB J 2: 108-115.
9. Garde AH, Fomsgaard A & Høiby N (1995) An easy microtiter assay for quantitation of cytokine induction by lipopolysaccharide (LSP) and activity of LSP-binding serum components. APMIS 103: 286-292.
10. Gardlund B, Sjolin J, Nilsson A, Roll M,Wickerts CJ &Wretlind B (1995) Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 172: 296-301.
11. Goto S, Sakai S, Kera J, Suma Y, Soma GI & Takeuchi S (1996) Intradermal administration of lipopolysaccharide in treatment of human cancer. Cancer Immunol Immunother 42: 255-261.
12. 15N] nitrate in biological fluids. Anal Biochem 126: 131-138.
13. Grivennikov SI, Tumanov AV, Liepinsh DJ et al. (2005) Distinct and nonredundant in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious effects. Immunity 22: 93-104.
14. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA, Cerami A, Shires GT & Lowry SF (1988) Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 166: 147-153.
15. Hirschfeld M, Ying M, Weis JH, Vogel SN & Weis JJ (2000) Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165: 618-622.
16. Johnson AG (1994) Molecular adjuvants and immunomodulators: new approaches to immunization. Clin Microbiol Rev 7: 277-289.
17. Kishimoto N, Kosako Y & Tano T (1991) Acidobacterium capsulatum gen. nov., sp. nov.: an acidophilic chemorganotrophic bacterium containing menaquinone from acidic mineral environment. Curr Microbiol 22: 1-7.
18. Kobayashi S, Kawata T, Kimura A, Miyamoto K, Katayama K, Yamatsu I, Rossignol DP, Christ WJ & Kishi Y (1998) Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonist. Antimicrob Agents Chemother 42: 2824-2829.
19. Landmann R, Knopf HP, Link S, Sansano S, Schumann R & ZimmerliW(1996) Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun 64: 1762-1769.
20. Lee J, Kravchenko V, Kirkland TN, Han J, Mackman N, Moriarty A, Leturcq D, Tobias PS & Ulevitch RJ (1993) Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc Natl Acad Sci USA 90: 9930-9934.
21. Mayer H, Bhat UR, Masoud H, Radziejewska-Lebrecht J, Widemann C & Krauss JH (1989) Bacterial lipopolysaccharides. Pure Appl Chem 61: 1271-1282.
22. Nayak A (1999) Studies on new nontoxic lipopolysaccharide, with therapeutic potentials, isolated from a new strain of soil bacteria. PhD Thesis, Jadavpur University, Kolkata.
23. Ogawa T, Asai Y, Yamamoto H, Taiji Y, Jinno T, Kodama T, Niwata S, Shimauchi H & Ochiai K (2000) Immunobiological activities of a chemically synthesized lipid A of Porphyromonas gingivalis. FEMS Immunol Med Microbiol 28: 273-281.
24. Proctor RA, Will JA, Burhop KE & Raetz CBH (1986) Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun 52: 905-907.
25. Riedemann NC, Neff TA, Guo R-F, Bernaki KD, Laudes IJ, Sarma JV, Lambris JD & Wards PA (2003) Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression. J Immunol 170: 503-507.
26. Rietschel ET, Kirikae T, Schade FU et al. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225.
27. Rigato O, Ujvari S, Castelo A & Salomao R (1996) Tumor necrosis factor alpha (TNF-α) and sepsis: evidence for a role in host defense. Infection 24: 314-318.
28. Sanchez-Cantu I, Rode HN, Yun TJ & Christon NV (1991) Tumor necrosis factor alone does not explain the lethal effect of lipopolysaccharide. Arch Surg 126: 231-235.
29. Strittmatter W, Weckesser J, Salimath PV & Galanos C (1983) Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol 155: 153-158.
30. Tsukioka D, Nishizawa T, Miyase T, Achiwa K, Suda T, Soma G & Mizuno D (1997) Structural characterization of lipid A obtained from Pantoea agglomerans lipopolysaccharide. FEMS Microbiol Lett 149: 239-244.
31. Urakami T, Tamaoka J, Suzuki KI & Komagata K (1989) Acidomonas gen nov., incorporating Acetobacter methanolicus as Acidomonas methanolica comb. Nov. Int J Syst Bacteriol 39: 50-55.
32. Wagge A, Brandtzaeg P, Halstensen A, Kierulf P & Espevik T (1989) The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 169: 333-338.
33. West MA & Heagy W (2002) Endotoxin tolerance: a review. Crit Care Med 30: S64-S73.
34. Westphal O & Jann K (1965) Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 5: 83-90.
35. Zahringer U, Knirel YA, Lindner B, Helbig JH, Sonesson A, Marre R & Rietschel ET (1995) The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res 392: 113-139.